Company / Current Assets per Share
MoonLake Immunotherapeutics Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.54
FY2025
5-year range
$1.23 / $10.47
FY2021-FY2025
Trend
-13.3%
vs FY2024
Sector context
#112 of 210
Health Care
What the data says
At $6.54, MoonLake Immunotherapeutics's current assets per share ranks #112 of 210 in the Health Care sector. Declined from $10.47 to $6.54 over the past 2 years.
Based on SEC 10-K filings.
6.54 in FY2025 with a 5-year CAGR of +90.6%.
Declined from $10.47 to $6.54 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +35.9%
- 5-Year CAGR
- +90.6%
- 10-Year CAGR
- -
Sector benchmark
#112 of 210 in Health CareTop 53% of 210This company $6.54 Sector average $170.65
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 13.3% year-over-year.
- Ranks #112 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.54 | -13.3% |
| FY2024 | $7.54 | -27.9% |
| FY2023 | $10.47 | +301.7% |
| FY2022 | $2.61 | +112.0% |
| FY2021 | $1.23 | +373.1% |
| FY2020 | $0.26 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026